Oncology Institute Balance Sheet Health
Financial Health criteria checks 3/6
Oncology Institute has a total shareholder equity of $15.5M and total debt of $91.5M, which brings its debt-to-equity ratio to 591.2%. Its total assets and total liabilities are $179.2M and $163.7M respectively.
Key information
591.2%
Debt to equity ratio
US$91.54m
Debt
| Interest coverage ratio | n/a |
| Cash | US$47.40m |
| Equity | US$15.48m |
| Total liabilities | US$163.70m |
| Total assets | US$179.18m |
Recent financial health updates
Recent updates
The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 195% But Many Are Still Ignoring The Company
Jan 18
A Piece Of The Puzzle Missing From The Oncology Institute, Inc.'s (NASDAQ:TOI) 28% Share Price Climb
Jul 19The Oncology Institute, Inc. (NASDAQ:TOI) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 05Not Many Are Piling Into The Oncology Institute, Inc. (NASDAQ:TOI) Stock Yet As It Plummets 28%
Mar 21Is Oncology Institute (NASDAQ:TOI) A Risky Investment?
Mar 05The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 49% But Many Are Still Ignoring The Company
Nov 10The Oncology Institute swings to Q2 GAAP loss per share from year-ago profit
Aug 09Shareholders Shouldn’t Be Too Comfortable With Oncology Institute's (NASDAQ:TOI) Strong Earnings
May 18Financial Position Analysis
Short Term Liabilities: TOI's short term assets ($116.4M) exceed its short term liabilities ($46.8M).
Long Term Liabilities: TOI's short term assets ($116.4M) do not cover its long term liabilities ($116.9M).
Debt to Equity History and Analysis
Debt Level: TOI's net debt to equity ratio (285.1%) is considered high.
Reducing Debt: Insufficient data to determine if TOI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TOI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TOI has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 31.4% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 01:52 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The Oncology Institute, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alexander Draper | Guggenheim Securities, LLC |
| Brian Tanquilut | Jefferies LLC |